TrialBMJ open diabetes research & care2023

Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study.

Akihiro Kudo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.